Scientific Breakthrough in the Lab

Aug 15, 2024

We are delighted to report that recent experiments have enabled us to identify biomarkers for lung, pancreatic, stomach and colon cancers. This means that, whereas to this point most of our work was focused on the early detection of a single-cancer type, we are able to expand our work into an even more exciting direction.

Dr Sophia Fang, our Chief Scientific Officer, said: “Over the past three weeks we have identified a pan-cancer biomarker panel that has been proven effective for multiple cancers using a simple PCR assay. Preliminary clinical validation data supports its efficacy. We are optimistic that this panel will be applicable to additional tumor types, and we are expanding the sample size for further clinical validation.”

Real scientific breakthroughs do not happen every day. But the experiments conducted in our Brooklyn laboratory have enabled such a breakthrough and, as Epi One CEO Michael Marquardt states with our StartEngine crowdfunding campaign in mind: “This will add significant value to our company.”

The equity crowdfunding campaign is now live on StartEngine, offering investors the chance to be a part of Epi One’s growth and innovation. You can find details of the offering at StartEngine’s Epi One offering page.

MORE NEWS

Transforming Early Cancer Detection: Latest Webinar Highlights

At Epi One, we're on a mission to revolutionize how cancer is detected and diagnosed. During our recent ...

Join Us for Epi One’s Final Investment Webinar – A Conversation with CEO Michael Marquardt and Chief Scientist & Founder Dr. Fang

As our StartEngine campaign enters its final weeks, we're excited to invite you to a special webinar event ...

Epi One: Top Reasons to Invest Today

7 Reasons to Invest in Epi One: Transforming Cancer Detection Imagine a world where a simple test could ...

Webinar Recap: Transforming Lives Through Early Cancer Detection

At Epi One, we're on a mission to change the landscape of cancer detection. Our recent webinar, led ...

Market Opportunity with Epi One

Market Opportunity with Epi One We believe Epi One is at the vanguard of the rapidly evolving cancer ...

$1 Million Raised from Equity Crowdfunding

We are incredibly excited and humbled to announce that Epi One has now surpassed the $1 million mark ...

StartEngine Campaign Surpasses $500,000

We are thrilled to announce that following the launch of our equity crowdfunding campaign on StartEngine on May ...
cancer diagnosis tools

Equity Crowdfunding Campaign for Cancer Diagnosis Tools

We are excited to announce the launch of our equity crowdfunding campaign on StartEngine. This campaign offers individuals ...
cancer diagnosis technology

Cancer Diagnosis Angel Investment Tops $1 million

As revealed on CityBiz this week, we are delighted to confirm that ahead of our upcoming launch on ...
early detection of cancer symptoms

Early Detection of Cancer Symptoms

We have discovered a way to make early detection of cancer symptoms accurate, affordable and a reality for ...
Scroll to Top